Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 40: 288-295, 1994;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Owens, M. J.
Right arrow Articles by Nemeroff, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Owens, M. J.
Right arrow Articles by Nemeroff, C. B.

Clinical Chemistry, Vol 40, 288-295, Copyright © 1994 by American Association for Clinical Chemistry

Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter

MJ Owens and CB Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322.

Considerable evidence has accrued in the last two decades to support the hypothesis that alterations in serotonergic neuronal function in the central nervous system occur in patients with major depression. These findings include the following: (a) reduced cerebrospinal fluid (CSF) concentrations of 5-hydroxyindoleacetic acid (5-HIAA), the major metabolite of serotonin (5-HT) in drug-free depressed patients; (b) reduced concentrations of 5-HT and 5-HIAA in postmortem brain tissue of depressed and (or) suicidal patients; (c) decreased plasma tryptophan concentrations in depressed patients and a profound relapse in remitted depressed patients who have responded to a serotonergic antidepressant when brain tryptophan availability is reduced; (d) in general, all clinically efficacious antidepressants augment 5-HT neurotransmission following chronic treatment; (e) clinically efficacious antidepressant action by all inhibitors of 5-HT uptake; (f) increases in the density of 5-HT2 binding sites in postmortem brain tissue of depressed patients and suicide victims, as well as in platelets of drug-free depressed patients; (g) decreased number of 5-HT transporter (determined with [3H]imipramine or [3H]paroxetine) binding sites in postmortem brain tissue of suicide victims and depressed patients and in platelets of drug-free depressed patients. In our studies, this reduction in platelet 5-HT transporter binding is not due to prior antidepressant treatment of hypercortisolemia and is not observed in mania, Alzheimer disease, schizophrenia, panic disorder, fibromyalgia, or atypical depression. In a pilot study, this deficit predicted treatment response to an experimental antidepressant. These findings support the hypothesis that alterations in 5-HT neurons play a role in the pathophysiology of depression.


The following articles in journals at HighWire Press have cited this article:


Home page
 Soc Cogn Affect NeurosciHome page
L. Wang, O. Mullette-Gillman, K. M. Gadde, C. M. Kuhn, G. McCarthy, and S. A. Huettel
The effect of acute tryptophan depletion on emotional distraction and subsequent memory
Soc Cogn Affect Neurosci, July 23, 2009; (2009) nsp025v1.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
C. Firk and C. R. Markus
Review: Serotonin by stress interaction: a susceptibility factor for the development of depression?
J Psychopharmacol, July 1, 2007; 21(5): 538 - 544.
[Abstract] [PDF]

Home page
 Br. J. PsychiatryHome page
M. R. GARLAND, B. HALLAHAN, M. McNAMARA, P. A. CARNEY, H. GRIMES, J. R. HIBBELN, A. HARKIN, and R. M. CONROY
Lipids and essential fatty acids in patients presenting with self-harm
The British Journal of Psychiatry, February 1, 2007; 190(2): 112 - 117.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
A. Neumeister, X.-Z. Hu, D. A. Luckenbaugh, M. Schwarz, A. C. Nugent, O. Bonne, P. Herscovitch, D. Goldman, W. C. Drevets, and D. S. Charney
Differential Effects of 5-HTTLPR Genotypes on the Behavioral and Neural Responses to Tryptophan Depletion in Patients With Major Depression and Controls.
Arch Gen Psychiatry, September 1, 2006; 63(9): 978 - 986.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
J.-M. Launay, B. Schneider, S. Loric, M. Da Prada, and O. Kellermann
Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells
FASEB J, September 1, 2006; 20(11): 1843 - 1854.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
J. M. McCaffery, N. Frasure-Smith, M.-P. Dube, P. Theroux, G. A. Rouleau, Q. Duan, and F. Lesperance
Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin.
Psychosom Med, March 1, 2006; 68(2): 187 - 200.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
R. V. Parsey, R. S. Hastings, M. A. Oquendo, Y.-y. Huang, N. Simpson, J. Arcement, Y. Huang, R. T. Ogden, R. L. Van Heertum, V. Arango, et al.
Lower Serotonin Transporter Binding Potential in the Human Brain During Major Depressive Episodes
Am J Psychiatry, January 1, 2006; 163(1): 52 - 58.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
Z. Zhou, A. Roy, R. Lipsky, K. Kuchipudi, G. Zhu, J. Taubman, M.-A. Enoch, M. Virkkunen, and D. Goldman
Haplotype-Based Linkage of Tryptophan Hydroxylase 2 to Suicide Attempt, Major Depression, and Cerebrospinal Fluid 5-Hydroxyindoleacetic Acid in 4 Populations
Arch Gen Psychiatry, October 1, 2005; 62(10): 1109 - 1118.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
L. D. Jayanthi, D. J. Samuvel, R. D. Blakely, and S. Ramamoorthy
Evidence for Biphasic Effects of Protein Kinase C on Serotonin Transporter Function, Endocytosis, and Phosphorylation
Mol. Pharmacol., June 1, 2005; 67(6): 2077 - 2087.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
W. D. Taylor, D. C. Steffens, M. E. Payne, J. R. MacFall, D. A. Marchuk, I. K. Svenson, and K. R. R. Krishnan
Influence of Serotonin Transporter Promoter Region Polymorphisms on Hippocampal Volumes in Late-Life Depression
Arch Gen Psychiatry, May 1, 2005; 62(5): 537 - 544.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C.-B. Zhu, A. M. Carneiro, W. R. Dostmann, W. A. Hewlett, and R. D. Blakely
p38 MAPK Activation Elevates Serotonin Transport Activity via a Trafficking-independent, Protein Phosphatase 2A-dependent Process
J. Biol. Chem., April 22, 2005; 280(16): 15649 - 15658.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
S U Shah, A White, S White, and W A Littler
Heart and mind: (1) relationship between cardiovascular and psychiatric conditions
Postgrad. Med. J., December 1, 2004; 80(950): 683 - 689.
[Abstract] [Full Text] [PDF]

Home page
 Adv. Psychiatr. Treat.Home page
E. M. Tsapakis, A. Basu, and K. J. Aitchison
Clinical relevance of discoveries in psychopharmacogenetics
Adv. Psychiatr. Treat., November 1, 2004; 10(6): 455 - 465.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. B. Larsen, B. Elfving, and O. Wiborg
The Chicken Serotonin Transporter Discriminates between Serotonin-selective Reuptake Inhibitors: A SPECIES-SCANNING MUTAGENESIS STUDY
J. Biol. Chem., October 1, 2004; 279(40): 42147 - 42156.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
H. S. Lett, J. A. Blumenthal, M. A. Babyak, A. Sherwood, T. Strauman, C. Robins, and M. F. Newman
Depression as a Risk Factor for Coronary Artery Disease: Evidence, Mechanisms, and Treatment
Psychosom Med, May 1, 2004; 66(3): 305 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
T. Frodl, E. M. Meisenzahl, P. Zill, T. Baghai, D. Rujescu, G. Leinsinger, R. Bottlender, C. Schule, P. Zwanzger, R. R. Engel, et al.
Reduced Hippocampal Volumes Associated With the Long Variant of the Serotonin Transporter Polymorphism in Major Depression
Arch Gen Psychiatry, February 1, 2004; 61(2): 177 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
K. L. L. Movig, M. W. H. E. Janssen, J. de Waal Malefijt, P. J. Kabel, H. G. M. Leufkens, and A. C. G. Egberts
Relationship of Serotonergic Antidepressants and Need for Blood Transfusion in Orthopedic Surgical Patients
Arch Intern Med, October 27, 2003; 163(19): 2354 - 2358.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
A. Schins, A. Honig, H. Crijns, L. Baur, and K. Hamulyak
Increased Coronary Events in Depressed Cardiovascular Patients: 5-HT2A Receptor as Missing Link?
Psychosom Med, September 1, 2003; 65(5): 729 - 737.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
A. Neumeister, A. Konstantinidis, J. Stastny, M. J. Schwarz, O. Vitouch, M. Willeit, N. Praschak-Rieder, J. Zach, M. de Zwaan, B. Bondy, et al.
Association Between Serotonin Transporter Gene Promoter Polymorphism (5HTTLPR) and Behavioral Responses to Tryptophan Depletion in Healthy Women With and Without Family History of Depression
Arch Gen Psychiatry, July 1, 2002; 59(7): 613 - 620.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. Murr, M. Ledochowski, and D. Fuchs
Chronic Immune Stimulation May Link Ischemic Heart Disease With Depression
Circulation, April 9, 2002; 105 (14): e83 - e83.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
T. Mantere, E. Tupala, H. Hall, T. Sarkioja, P. Rasanen, K. Bergstrom, J. Callaway, and J. Tiihonen
Serotonin Transporter Distribution and Density in the Cerebral Cortex of Alcoholic and Nonalcoholic Comparison Subjects: A Whole-Hemisphere Autoradiography Study
Am J Psychiatry, April 1, 2002; 159(4): 599 - 606.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. D. Blakely
Physiological Genomics of Antidepressant Targets: Keeping the Periphery in Mind
J. Neurosci., November 1, 2001; 21(21): 8319 - 8323.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
R. J. Croft, A. Klugman, T. Baldeweg, and J. H. Gruzelier
Electrophysiological Evidence of Serotonergic Impairment in Long-Term MDMA (""Ecstasy"") Users
Am J Psychiatry, October 1, 2001; 158(10): 1687 - 1692.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
E. Legangneux, J. J. Mora, O. Spreux-Varoquaux, I. Thorin, M. Herrou, G. Alvado, and C. Gomeni
Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome
Rheumatology, March 1, 2001; 40(3): 290 - 296.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. J. Lucassen, M. B. Muller, F. Holsboer, J. Bauer, A. Holtrop, J. Wouda, W. J. G. Hoogendijk, E. R. De Kloet, and D. F. Swaab
Hippocampal Apoptosis in Major Depression Is a Minor Event and Absent from Subareas at Risk for Glucocorticoid Overexposure
Am. J. Pathol., February 1, 2001; 158(2): 453 - 468.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. L. Bauman, S. Apparsundaram, S. Ramamoorthy, B. E. Wadzinski, R. A. Vaughan, and R. D. Blakely
Cocaine and Antidepressant-Sensitive Biogenic Amine Transporters Exist in Regulated Complexes with Protein Phosphatase 2A
J. Neurosci., October 15, 2000; 20(20): 7571 - 7578.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
J. J. Mann, Y.-y. Huang, M. D. Underwood, S. A. Kassir, S. Oppenheim, T. M. Kelly, A. J. Dwork, and V. Arango
A Serotonin Transporter Gene Promoter Polymorphism (5-HTTLPR) and Prefrontal Cortical Binding in Major Depression and Suicide
Arch Gen Psychiatry, August 1, 2000; 57(8): 729 - 738.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
E. Dieperink, M. Willenbring, and S. B. Ho
Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review
Am J Psychiatry, June 1, 2000; 157(6): 867 - 876.
[Abstract] [Full Text]

Home page
 Am. J. PsychiatryHome page
M. Preisig, F. Bellivier, B. T. Fenton, P. Baud, A. Berney, P. Courtet, P. Hardy, J. Golaz, M. Leboyer, J. Mallet, et al.
Association Between Bipolar Disorder and Monoamine Oxidase A Gene Polymorphisms: Results of a Multicenter Study
Am J Psychiatry, June 1, 2000; 157(6): 948 - 955.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
L. A. Mamounas, C. A. Altar, M. E. Blue, D. R. Kaplan, L. Tessarollo, and W. E. Lyons
BDNF Promotes the Regenerative Sprouting, But Not Survival, of Injured Serotonergic Axons in the Adult Rat Brain
J. Neurosci., January 15, 2000; 20(2): 771 - 782.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
E. Lenze, D. Cross, D. McKeel, R. J. Neuman, and Y. I. Sheline
White Matter Hyperintensities and Gray Matter Lesions in Physically Healthy Depressed Subjects
Am J Psychiatry, October 1, 1999; 156(10): 1602 - 1607.
[Abstract] [Full Text]

Home page
 ScienceHome page
S. Ramamoorthy and R. D. Blakely
Phosphorylation and Sequestration of Serotonin Transporters Differentially Modulated by Psychostimulants
Science, July 30, 1999; 285(5428): 763 - 766.
[Abstract] [Full Text]

Home page
 J Geriatr Psychiatry NeurolHome page
M. A. Menza, B. Palermo, R. DiPaola, J. I. Sage, and M. H. Ricketts
Depression and Anxiety in Parkinson's Disease: Possible Effect of Genetic Variation in the Serotonin Transporter
J Geriatr Psychiatry Neurol, July 1, 1999; 12(2): 49 - 52.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
D. L. Musselman, D. L. Evans, and C. B. Nemeroff
The Relationship of Depression to Cardiovascular Disease: Epidemiology, Biology, and Treatment
Arch Gen Psychiatry, July 1, 1998; 55(7): 580 - 592.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. Bengel, D. L. Murphy, A. M. Andrews, C. H. Wichems, D. Feltner, A. Heils, R. Mössner, H. Westphal, and K.-P. Lesch
Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine ("Ecstasy") in Serotonin Transporter-Deficient Mice
Mol. Pharmacol., April 1, 1998; 53(4): 649 - 655.
[Abstract] [Full Text]

Home page
 NeuroscientistHome page
K.-P. Lesch
Review : Serotonin Transporter and Psychiatric Disorders: Listening to the Gene
Neuroscientist, January 1, 1998; 4(1): 25 - 34.
[Abstract] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. M. Cabrera-Vera, F. Garcia, W. Pinto, and G. Battaglia
Effect of Prenatal Fluoxetine (Prozac) Exposure on Brain Serotonin Neurons in Prepubescent and Adult Male Rat Offspring
J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 138 - 145.
[Abstract] [Full Text]

Home page
 ScienceHome page
K.-P. Lesch, D. Bengel, A. Heils, S. Z. Sabol, B. D. Greenberg, S. Petri, J. Benjamin, C. R. Müller, D. H. Hamer, and D. L. Murphy
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
Science, November 29, 1996; 274(5292): 1527 - 1531.
[Abstract] [Full Text]

Home page
 J PsychopharmacolHome page
T. Dinan
Treatment approaches to therapy-resistant depression
J Psychopharmacol, January 1, 1995; 9(2_suppl): 199 - 204.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Association for Clinical Chemistry.